NEW YORK--(BUSINESS WIRE)--The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Ambit Biosciences Corporation (NasdaqGM:AMBI) (“Ambit Biosciences”) in connection with the sale of the Company to Daiichi Sankyo Company, Ltd.
Click here to learn about the case: http://docs.wongesq.com/AMBI-Info-Request-Form-425. There is no cost or obligation to you.
Under the terms of the transaction, Ambit Biosciences shareholders will receive $15 in cash for each share of Ambit Biosciences stock they own. The investigation concerns whether the Board of Ambit Biosciences breached their fiduciary duty to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Daiichi Sankyo Company, Ltd. is underpaying for Ambit Biosciences shares.
If you own common stock in Ambit Biosciences and wish to obtain additional information, please contact Vincent Wong, Esq. either via email email@example.com, by telephone at 212.425.1140, or visit http://docs.wongesq.com/AMBI-Info-Request-Form-425.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.